Most people expect their heartbeat to be steady and regular. When the rhythm suddenly quickens or seems to skip beats, it can be concerning. Fortunately, ...

CoreMap's latest fundraise almost doubles the privately held company's funds raised since its founding in 2016.

Most people expect their heartbeat to be steady and regular. When the rhythm suddenly speeds up or feels as though it skips ...

Cardiac electrophysiology specializes in diagnosing and treating heart electrical system disorders, with comprehensive AFib ...

CoreMap raised money to supplement the government support, disclosing a $10.5 million Series A round in 2020 and a $23 ...

Electrophysiology is the fastest-growing subspecialty in cardiology, and hospitals and ASCs are each racing to expand capacity for it. But the physicians who perform ablations, implant devices and ...

A screenshot from a marketing video demonstrating the CoreMap technology CoreMap announced today that it closed an oversubscribed $37 million Series C financing round led by medtech giant Medtronic.

A growing number of people across Asia Pacific are living with a common heart rhythm disorder that can raise the risk of ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the NANOPULSE-AF Study ...

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities ...

A new heart ablation procedure being used across UCHealth to control atrial fibrillation is helping doctors treat more ...

Aqua Medical, Inc., a clinical-stage medical technology company pioneering Endoscopic Metabolic Restoration, today announced the successful treatment of the first U.S. patient in its U.S. Food and ...